Rocket Lab’s Iridium Play: A $7.6 Billion Wager Financed One ATM Tender at a Time

The paperwork is clearing, the financing is stacking up, and the clock is now ticking toward a mid-2027 close. Rocket Lab’s proposed acquisition of Iridium Communications crossed a pair of regulatory thresholds this week, with the Hart-Scott-Rodino antitrust waiting period expiring on August 12 and the company submitting its S-4 registration statement to the SEC. The two firms had already filed jointly with the FCC on August 10 to transfer operating licenses.

The deal, valued at roughly $7.59 billion, would hand Iridium shareholders $27.00 per share in cash plus Rocket Lab equity on an exchange ratio sliding between 0.24 and 0.40 shares, depending on where the stock trades at closing. It is, by any measure, the boldest statement yet from a company that has spent the last two years transforming itself from a small-launch specialist into a vertically integrated space contractor.

A Bridge Loan, a Fresh ATM, and a Quiet Dilution

What makes the transaction notable isn’t just its size — it’s the machinery behind it. Rocket Lab has secured a $3.6 billion bridge loan at an effective interest rate of roughly 8 percent to carry the deal through to permanent financing. To keep that debt from lingering on the balance sheet, the company launched a new at-the-market equity offering on Wednesday, authorizing up to $1.94 billion in fresh share sales. The program replaces an earlier ATM agreement from May that had already raised over a billion dollars, and it does not expand the company’s total authorization.

Here’s the detail that deserves attention: the ATM is not contingent on the Iridium deal closing. Rocket Lab can draw down capital whether the acquisition proceeds or collapses. That effectively means shareholders are absorbing ongoing dilution as a cost of doing business — a structural reality the market has already begun to price in, with the stock shedding between roughly two and three-plus percent on individual trading days this week.

Record Revenue Masks a Neutron Slip

The financing gymnastics are only tolerable because the underlying business keeps delivering. Rocket Lab posted record second-quarter revenue of $234.07 million, up 62 percent year over year, alongside a backlog that surged 137 percent to $2.36 billion. Space Systems, the satellite-manufacturing side of the house, grew from $97.9 million to $189.5 million, while the legacy launch segment slipped slightly to $44.6 million. A $397 million U.S. Space Force contract for “flatellite” spacecraft underscores how far the center of gravity has shifted toward defense and satellite infrastructure.

The quarter wasn’t flawless. The company’s loss per share of $0.08 came in shy of the consensus estimate of a $0.06 loss, initially knocking the stock down around five percent before it recovered. Management’s third-quarter guidance calls for revenue between $250 million and $265 million, with an adjusted operating loss of $17 million to $23 million.

Should investors sell immediately? Or is it worth buying Rocket Lab?

The bigger overhang, though, is Neutron. The heavy-lift rocket’s debut, originally slated for the fourth quarter of 2026, now looks increasingly likely to slip into 2027. Rocket Lab says the vehicle will be transported to the launch pad in the fourth quarter, but a launch this year would require qualification tests and critical reviews to align perfectly — a tight window the company itself acknowledges. CEO Peter Beck has remained conspicuously vague on the subject, and Reuters and Bloomberg both reported that the company has conceded additional risks, with a first flight as late as 2027 not ruled out.

None of that has stopped Neutron from attracting customers. Rocket Lab recently signed a deal to launch a Kepler Communications satellite on Neutron, with liftoff slated no earlier than 2028 from Launch Complex 3 on Wallops Island, Virginia.

The Steady Hand of Electron

While the heavy lifter waits, the workhorse keeps flying. On August 6, Rocket Lab completed its 92nd Electron mission, the eighth launch for Japanese customer iQPS, delivering the QPS-SAR-13 satellite to orbit. Another iQPS launch was scheduled for later in August.

Where the Stock Stands

The shares trade at €68.40, down 1.9 percent on the day and 4.5 percent on the week, though still up 11 percent year to date. That leaves the stock roughly 49 percent below its 52-week high of €133.80, reached in late May. The secondary article cites a slightly different current price of €69.70, with a 13 percent year-to-date gain and an 89 percent advance over twelve months.

Analyst targets span a wide range, reflecting genuine uncertainty. Cantor Fitzgerald raised its price target to $122 from $96 on August 11, reaffirming an “Overweight” rating — a move made right after earnings and before the latest Neutron headlines. Citizens JMP sits at $130, while Piper Sandler holds a neutral stance at just $83. The consensus lands near $110.65.

The broader picture is one of a company financing growth through market confidence rather than cash flow — a pattern familiar from other young industries. Whether the Iridium deal closes or not, Rocket Lab is signaling it intends to play in the same league as SpaceX, whose space segment generated $962 million in quarterly revenue. The wager is enormous, the dilution is real, and the payoff, if it comes, will take years to materialize. For now, the market is watching the paperwork — and the launch pad in Virginia — with equal intensity.